Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.5M
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
+32.4K
-
Total reported value, excl. options
-
$1.26B
-
Value change
-
+$4.49M
-
Put/Call ratio
-
1.75
-
Number of buys
-
103
-
Number of sells
-
-93
-
Price
-
$67.28
Significant Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q2 2023
225 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock as of Q2 2023.
LEMAITRE VASCULAR INC - Common Stock (LMAT) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 22.5M outstanding shares and own 83.63% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.25M shares), Conestoga Capital Advisors, LLC (1.86M shares), VANGUARD GROUP INC (1.48M shares), Copeland Capital Management, LLC (1.23M shares), GENEVA CAPITAL MANAGEMENT LLC (902K shares), STATE STREET CORP (780K shares), Ranger Investment Management, L.P. (776K shares), DIMENSIONAL FUND ADVISORS LP (669K shares), GEODE CAPITAL MANAGEMENT, LLC (421K shares), and CONGRESS ASSET MANAGEMENT CO /MA (373K shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.